| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |